Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial

Peter J. Kuebler, Megha L. Mehrotra, J. Jeff McConnell, Sara J. Holditch, Brian I. Shaw, Leandro F. Tarosso, Kaitlyn S. Leadabrand, Jeffrey M. Milush, Vanessa A. York, Rui André Saraiva Raposo, Rex G. Cheng, Emily M. Eriksson, Vanessa McMahan, David V. Glidden, Stephen Shiboski, Robert M. Grant, Douglas F. Nixon, and Esper G. Kallás
  1. aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  2. bInstitute of Virology & Immunology, Gladstone Institutes, San Francisco, CA 94158;
  3. cDivision of Clinical Immunology and Allergy, University of São Paulo, São Paulo, Brazil 01246;
  4. dDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC 20037;
  5. eDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA 94158;
  6. fDepartment of Medicine, University of California, San Francisco, CA 94143

See allHide authors and affiliations

PNAS first published June 22, 2015; https://doi.org/10.1073/pnas.1501443112
Peter J. Kuebler
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: peter.kuebler@ucsf.edu
Megha L. Mehrotra
bInstitute of Virology & Immunology, Gladstone Institutes, San Francisco, CA 94158;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Jeff McConnell
bInstitute of Virology & Immunology, Gladstone Institutes, San Francisco, CA 94158;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara J. Holditch
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian I. Shaw
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leandro F. Tarosso
cDivision of Clinical Immunology and Allergy, University of São Paulo, São Paulo, Brazil 01246;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaitlyn S. Leadabrand
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey M. Milush
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa A. York
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rui André Saraiva Raposo
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
dDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC 20037;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rex G. Cheng
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily M. Eriksson
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa McMahan
bInstitute of Virology & Immunology, Gladstone Institutes, San Francisco, CA 94158;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David V. Glidden
eDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA 94158;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Shiboski
eDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA 94158;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert M. Grant
bInstitute of Virology & Immunology, Gladstone Institutes, San Francisco, CA 94158;
fDepartment of Medicine, University of California, San Francisco, CA 94143
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas F. Nixon
aDivision of Experimental Medicine, University of California, San Francisco, CA 94110;
dDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC 20037;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esper G. Kallás
cDivision of Clinical Immunology and Allergy, University of São Paulo, São Paulo, Brazil 01246;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  1. Edited by Robert C. Gallo, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, and approved May 27, 2015 (received for review January 22, 2015)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

The demonstration and clinical relevance of HIV-1–specific immune responses in exposed but uninfected seronegative individuals have been controversial. Studies seeking to detect these responses have generally been small in size and have varied in study population, methods of detection, and control groups. We conducted a large case–control immunology study of participants in the Preexposure Prophylaxis Initiative (iPrEx) chemoprophylaxis trial, selecting preinfection time points for those who became infected compared with persistently HIV-1–negative controls. We confirmed that HIV-1–specific responses are present in exposed uninfected individuals, sometimes at very high magnitude. HIV-1–specific responses also correlated with infection risk.

Abstract

HIV-1–specific T-cell responses in exposed seronegative subjects suggest that a viral breach of the exposure site is more common than current transmission rates would suggest and that host immunity can extinguish subsequent infection foci. The Preexposure Prophylaxis Initiative (iPrEx) chemoprophylaxis trial provided an opportunity to rigorously investigate these responses in a case–control immunology study; 84 preinfection peripheral blood mononuclear cell samples from individuals enrolled in the iPrEx trial who later seroconverted were matched with 480 samples from enrolled subjects who remained seronegative from both the placebo and active treatment arms. T-cell responses to HIV-1 Gag, Protease, Integrase, Reverse Transcriptase, Vif, and Nef antigens were quantified for all subjects in an IFN-γ enzyme-linked immunospot (ELISpot) assay. IFN-γ responses varied in magnitude and frequency across subjects. A positive response was more prevalent in those who remained persistently HIV-1–negative for Gag (P = 0.007), Integrase (P < 0.001), Vif (P < 0.001), and Nef (P < 0.001). When correlated with outcomes in the iPrEx trial, Vif- and Integrase-specific T-cell responses were associated with reduced HIV-1 infection risk [hazard ratio (HR) = 0.36, 95% confidence interval (95% CI) = 0.19–0.66 and HR = 0.52, 95% CI = 0.28–0.96, respectively]. Antigen-specific responses were independent of emtricitabine/tenofovir disoproxil fumarate use. IFN-γ secretion in the ELISpot was confirmed using multiparametric flow cytometry and largely attributed to effector memory CD4+ or CD8+ T cells. Our results show that HIV-1–specific T-cell immunity can be detected in exposed but uninfected individuals and that these T-cell responses can differentiate individuals according to infection outcomes.

  • HIV-1
  • T cell
  • designated HIV-1–exposed seronegative
  • preexposure chemoprophylaxis
  • vaccine

Footnotes

  • ↵1To whom correspondence should be addressed. Email: peter.kuebler{at}ucsf.edu.
  • ↵2M.L.M., J.J.M., S.J.H., and B.I.S. contributed equally to this work.

  • ↵3Deceased January 25, 2014.

  • ↵4Present address: Department of Medical Biology, Walter and Eliza Hall Institute of Medical Research and University of Melbourne, Parkville, VIC 3052, Australia.

  • ↵5R.M.G., D.F.N., and E.G.K. contributed equally to this work as senior authors.

  • Author contributions: P.J.K., M.L.M., J.J.M., S.J.H., B.I.S., L.F.T., R.G.C., E.M.E., V.M., D.V.G., S.S., R.M.G., D.F.N., and E.G.K. designed research; P.J.K., M.L.M., S.J.H., B.I.S., L.F.T., K.S.L., J.M.M., V.A.Y., R.A.S.R., and D.V.G. performed research; M.L.M., J.M.M., V.A.Y., D.V.G., and S.S. contributed new reagents/analytic tools; P.J.K., M.L.M., J.J.M., S.J.H., B.I.S., L.F.T., K.S.L., V.A.Y., D.V.G., S.S., R.M.G., D.F.N., and E.G.K. analyzed data; and P.J.K., M.L.M., J.J.M., S.J.H., B.I.S., L.F.T., K.S.L., J.M.M., V.A.Y., R.A.S.R., R.G.C., E.M.E., V.M., D.V.G., S.S., R.M.G., D.F.N., and E.G.K. wrote the paper.

  • The authors declare no conflict of interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1501443112/-/DCSupplemental.

Freely available online through the PNAS open access option.

Next
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Immune correlates analysis of an HIV-1 PrEP trial
Peter J. Kuebler, Megha L. Mehrotra, J. Jeff McConnell, Sara J. Holditch, Brian I. Shaw, Leandro F. Tarosso, Kaitlyn S. Leadabrand, Jeffrey M. Milush, Vanessa A. York, Rui André Saraiva Raposo, Rex G. Cheng, Emily M. Eriksson, Vanessa McMahan, David V. Glidden, Stephen Shiboski, Robert M. Grant, Douglas F. Nixon, Esper G. Kallás
Proceedings of the National Academy of Sciences Jun 2015, 201501443; DOI: 10.1073/pnas.1501443112

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Immune correlates analysis of an HIV-1 PrEP trial
Peter J. Kuebler, Megha L. Mehrotra, J. Jeff McConnell, Sara J. Holditch, Brian I. Shaw, Leandro F. Tarosso, Kaitlyn S. Leadabrand, Jeffrey M. Milush, Vanessa A. York, Rui André Saraiva Raposo, Rex G. Cheng, Emily M. Eriksson, Vanessa McMahan, David V. Glidden, Stephen Shiboski, Robert M. Grant, Douglas F. Nixon, Esper G. Kallás
Proceedings of the National Academy of Sciences Jun 2015, 201501443; DOI: 10.1073/pnas.1501443112
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley
Proceedings of the National Academy of Sciences: 118 (14)
Current Issue

Submit

Sign up for Article Alerts

Jump to section

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Smoke emanates from Japan’s Fukushima nuclear power plant a few days after tsunami damage
Core Concept: Muography offers a new way to see inside a multitude of objects
Muons penetrate much further than X-rays, they do essentially zero damage, and they are provided for free by the cosmos.
Image credit: Science Source/Digital Globe.
Water from a faucet fills a glass.
News Feature: How “forever chemicals” might impair the immune system
Researchers are exploring whether these ubiquitous fluorinated molecules might worsen infections or hamper vaccine effectiveness.
Image credit: Shutterstock/Dmitry Naumov.
Venus flytrap captures a fly.
Journal Club: Venus flytrap mechanism could shed light on how plants sense touch
One protein seems to play a key role in touch sensitivity for flytraps and other meat-eating plants.
Image credit: Shutterstock/Kuttelvaserova Stuchelova.
Illustration of groups of people chatting
Exploring the length of human conversations
Adam Mastroianni and Daniel Gilbert explore why conversations almost never end when people want them to.
Listen
Past PodcastsSubscribe
Panda bear hanging in a tree
How horse manure helps giant pandas tolerate cold
A study finds that giant pandas roll in horse manure to increase their cold tolerance.
Image credit: Fuwen Wei.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Cozzarelli Prize
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490